Peptide Politics — The Weekly

Brady Dale (Author of Front Stage Exit) joins Host Ron Steslow to examine the booming gray market for therapeutic peptides and what it reveals about medical freedom, institutional trust, and our resistance to the unfamiliar. They begin with the market itself, which Brady compares to the early crypto era he covered: people eager to risk their own money against regulators in the way. Next, they examine the cultural backlash, the moralism that casts GLP-1 weight loss as cheating, and a MAHA coalition at once wary of pharma yet drawn to gray-market compounds. Then, they turn to safety, where Brady argues the real hazard lies not in the peptides, but in contaminated manufacturing and careless injection. They also weigh the trouble of funding trials for compounds no one can patent. Finally, they consider bodily autonomy and whether medicine should restore a baseline health or enhance it. In Politicology+, they turn to a story Ron has been eager to bring to the show: the U.S. government has begun a historic effort to disclose its UFO files, and the officials behind the push say this is just the beginning. From whistleblower testimony about crash retrieval programs to a bipartisan Senate bill referencing "non-human intelligence" 22 times to the growing ranks of elite scientists taking it seriously, they dig into how we got here and why Congress can't get answers from its own government. POLITICOLOGY+ Not yet a Politicology+ member? Don’t miss all the extra episodes on the private, ad-free version of this podcast. Upgrade now at politicology.com/plus. Follow Brady’s work at Front Stage Exit: https://www.frontstageexit.com/ SPONSORS & PROMO CODES: https://bit.ly/44uAGZ8 Send your questions and ideas to podcast@politicology.com or leave a voicemail at ‪(703) 239-3068‬ Follow this week’s panel on X (formerly Twitter): https://x.com/RonSteslow https://x.com/BradyDale Learn more about your ad choices. Visit megaphone.fm/adchoices